Related references
Note: Only part of the references are listed.Biodegradable Metal Ion-Doped Mesoporous Silica Nanospheres Stimulate Anticancer Th1 Immune Response in Vivo
Xiupeng Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Stimulation of In Vivo Antitumor Immunity with Hollow Mesoporous Silica Nanospheres
Xiupeng Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Rod-shaped and fluorine-substituted hydroxyapatite free of molecular immunopotentiators stimulates anti-cancer immunity in vivo
Xiupeng Wang et al.
CHEMICAL COMMUNICATIONS (2016)
Combined administration of the apoptin gene and poly (I:C) induces potent anti-tumor immune response and inhibits growth of mouse mammary tumors
Shishir Kumar Gupta et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Highly efficient siRNA delivery from core-shell mesoporous silica nanoparticles with multifunctional polymer caps
Karin Moeller et al.
NANOSCALE (2016)
Hollow Structure Improved Anti-Cancer Immunity of Mesoporous Silica Nanospheres In Vivo
Xiupeng Wang et al.
SMALL (2016)
Comprehensive Mechanism Analysis of Mesoporous-Silica-Nanoparticle-Induced Cancer Immunotherapy
Xiupeng Wang et al.
ADVANCED HEALTHCARE MATERIALS (2016)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Monodispersed and Ordered Large-Pore Mesoporous Silica Nanospheres with Tunable Pore Structure for Magnetic Functionalization and Gene Delivery
Dechao Niu et al.
ADVANCED MATERIALS (2014)
Silica and Double-Stranded RNA Synergistically Induce Bronchial Epithelial Apoptosis and Airway Inflammation
Hirotoshi Unno et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Prediction of Specific Biomolecule Adsorption on Silica Surfaces as a Function of pH and Particle Size
Fateme S. Emami et al.
CHEMISTRY OF MATERIALS (2014)
Pore size-dependent immunogenic activity of mesoporous silica-based adjuvants in cancer immunotherapy
Xiupeng Wang et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2014)
Optimization of influencing factors of nucleic acid adsorption onto silica-coated magnetic particles: Application to viral nucleic acid extraction from serum
Ning Sun et al.
JOURNAL OF CHROMATOGRAPHY A (2014)
Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapy
Xiupeng Wang et al.
ACTA BIOMATERIALIA (2013)
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant
Annina M. Hafner et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Poly(I:C) exhibits an anti-cancer effect in human gastric adenocarcinoma cells which is dependent on RLRs
Jing Qu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Facile Large-Scale Synthesis of Monodisperse Mesoporous Silica Nanospheres with Tunable Pore Structure
Kun Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Correction: Large Domain Motions in Ago Protein Controlled by the Guide DNA-Strand Seed Region Determine the Ago-DNA-mRNA Complex Recognition Process
Zhen Xia et al.
PLoS One (2013)
Structural Determinants for Protein adsorption/non-adsorption to Silica Surface
Christelle Mathe et al.
PLOS ONE (2013)
Mesoporous Silica-Calcium Phosphate-Tuberculin Purified Protein Derivative Composites as an Effective Adjuvant for Cancer Immunotherapy
Xia Li et al.
ADVANCED HEALTHCARE MATERIALS (2013)
Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage
Jessica M. Rosenholm et al.
NANOMEDICINE (2012)
Adjuvant Properties of Mesoporous Silica Particles Tune the Development of Effector T Cells
Helen Vallhov et al.
SMALL (2012)
Immunization of mice by Hollow Mesoporous Silica Nanoparticles as carriers of Porcine Circovirus Type 2 ORF2 Protein
Hui-Chen Guo et al.
VIROLOGY JOURNAL (2012)
Efficient induction of anti-tumor immunity by a TAT-CEA fusion protein vaccine with poly(I:C) in a murine colorectal tumor model
Jung-Sun Park et al.
VACCINE (2011)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Biocompatibility, Biodistribution, and Drug-Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals
Jie Lu et al.
SMALL (2010)
Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15
Luciana V. Carvalho et al.
VACCINE (2010)
Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells
Stephen McCartney et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Monodispersed Mesoporous Silica Nanoparticles with Very Large Pores for Enhanced Adsorption and Release of DNA
Fei Gao et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2009)
Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
Christiane Stahl-Hennig et al.
PLOS PATHOGENS (2009)
Adsorption and elution characteristics of nucleic acids on silica surfaces and their use in designing a miniaturized purification unit
Tyson Poeckh et al.
ANALYTICAL BIOCHEMISTRY (2008)
Overexpression of Toll-like Receptors 3 and 4 in Synovial Tissue From Patients With Early Rheumatoid Arthritis Toll-like Receptor Expression in Early and Longstanding Arthritis
Caroline Ospelt et al.
ARTHRITIS AND RHEUMATISM (2008)
Targeting Poly(I:C) to the TLR3-Independent Pathway Boosts Effector CD8 T Cell Differentiation through IFN-α/β
Soo M. Ngoi et al.
JOURNAL OF IMMUNOLOGY (2008)
Mesoporous silica particles induce size dependent effects on human dendritic cells
Helen Vallhov et al.
NANO LETTERS (2007)
Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells:: a phenomenon absent from murine cell systems
Anna M. Lundberg et al.
BLOOD (2007)
The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C)
Colin Cunningham et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Ordered mesoporous silica SBA-15: A new effective adjuvant to induce antibody response
LP Mercuri et al.
SMALL (2006)
Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration
C Okada et al.
LIVER INTERNATIONAL (2005)
Viral double-stranded RNA aggravates lupus nephritis through toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells
PS Patole et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Cancer immunotherapy: A treatment for the masses
JN Blattman et al.
SCIENCE (2004)
Subcellular localization of toll-like receptor 3 in human dendritic cells
M Matsumoto et al.
JOURNAL OF IMMUNOLOGY (2003)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
Share Paper
